Cellectar Biosciences (CLRB)
Develops targeted radiotherapeutics for cancer through a phospholipid drug conjugate platform.
$2.21
vs last close−0.02 (−1.08%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.56
Revenue estimate
$17.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.01−$3.90−$3.39−$1.41−$0.53−$1.33−$0.57Pending
Estimate−$0.38−$5.11−$3.60−$1.91−$1.19−$1.89−$0.52−$0.56
Surprise+97.4%+23.7%+5.8%+26.2%+55.5%+29.4%−9.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————$12.8M$8.0M$12.0M$17.0M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.61 | — | — |
| Sep 2027 | −$0.61 | — | — |
| Jun 2027 | −$0.61 | — | — |
| Mar 2027 | −$0.51 | — | — |
| Dec 2026 | −$0.53 | — | — |
| Nov 2026 | −$0.56 | — | — |
| Aug 2026 | −$0.52 | −$0.57 | −9.6% |
| May 2026 | −$1.89 | −$1.33 | +29.4% |
| Mar 2026 | −$1.19 | −$0.53 | +55.5% |
| Nov 2025 | −$1.91 | −$1.41 | +26.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.61 | — | — | $3.6M | — | — | — |
| Sep 2027 | −$0.61 | — | — | $1.6M | — | — | — |
| Jun 2027 | −$0.61 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.51 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.53 | — | — | $24.9M | — | — | — |
| Nov 12, 2026 | −$0.56 | — | — | $17.0M | — | — | — |
| Aug 13, 2026 | −$0.52 | −$0.57 | −9.6% | $12.0M | — | — | −4.6% |
| May 14, 2026 | −$1.89 | −$1.33 | +29.4% | $8.0M | — | — | +8.8% |
| Mar 4, 2026 | −$1.19 | −$0.53 | +55.5% | $12.8M | — | — | +8.2% |
| Nov 13, 2025 | −$1.91 | −$1.41 | +26.2% | — | — | — | −18.0% |
| Aug 14, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 18, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 5, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 9, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 6, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 10, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 21, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 11, 2017 | |||||||
| Mar 15, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 11, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 11, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 12, 2015 |